Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (16)
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Import and export (31)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
798 result(s) found, displaying 701 to 725
-
-
Safety alerts
-
Safety alerts
-
Market actionsThe TGA advises that while PIP breast implants were recalled due to the use of unauthorised silicone, current evidence does not support routine removal in patients without symptoms, and individuals are encouraged to seek medical advice if concerned.
-
Market actionsAt the time of writing, the TGA has been advised that approximately 9,054 PIP breast implants have been implanted by surgeons between 2002 and 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace.
-
Safety alertsUpdated recommendations for Pneumovax 23 revaccination due to high rates of local reactions after repeat doses.
-
Safety alerts
-
Safety alerts
-
Safety alertsWe are updating safety information for Simvastatin due to new contraindications, precautions, and dosage recommendations. Consult your doctor if you have concerns.
-
-
Safety alerts
-
Safety alerts
-
Market actionsWe are recalling all batches of Savacol Antiseptic Mouth & Throat Rinse (alcohol-free) due to bacterial contamination.
-
-
Market actionsXigris (drotrecogin alfa) is being withdrawn from the market because it does not improve survival rates in severe sepsis patients. Stop using it and consult your doctor for alternative treatments.
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsAbout Octagam 5%: lifting of the voluntary recall
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
-